Real-time enrollment status for this high risk myelodysplastic syndrome clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:51 AM UTC
| NCT Number | NCT03214562 |
| Recruiting Status | Recruiting |
| Condition | High Risk Myelodysplastic Syndrome |
| Phase | PHASE1 |
| Target Enrollment | 116 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | March 5, 2026 (Mar 5, 2026) |
As of July 18, 2026: Clinical trial NCT03214562 is currently recruiting participants. This phase1 study for high risk myelodysplastic syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03214562 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03214562 was last updated Mar 5, 2026 (March 5, 2026). HelloStudys verifies this status automatically.